Levetiracetam
Product Images NDC 67296-1636

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 67296-1636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 01)

A dosage calculation formula showing the total daily dose (in mL/day) of Levetiracetam, calculated as the daily dose in mg/kg/day multiplied by patient weight in kg, divided by a concentration of 100 mg/mL.*

FDA Label Image

Figure 2 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 02)

A text panel showing a formula to calculate creatinine clearance (CLcr) using patient age, weight, and serum creatinine, with an adjustment factor for female patients and body surface area (BSA). It includes instructions for adjusting CLcr based on BSA in mL/min per 1.73 m².*

FDA Label Image

Structure (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 03)

Chemical structure of Levetiracetam, showing a pyrrolidone ring connected to a chiral carbon with attached ethyl group and amide functional group.*

FDA Label Image

Figure 4 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 04)

A bar chart comparing the percentage of patients in three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis shows percentage from 0% to 45%. Values displayed are 7.4% for Placebo (N=95), 37.1% for Levetiracetam 1000 mg/day (N=97), and 39.6% for Levetiracetam 3000 mg/day (N=101). Bars for both Levetiracetam groups have an asterisk above their values.*

FDA Label Image

Figure 5 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 05)

A bar graph comparing the percentage of patients among three groups: placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis represents the percentage of patients, ranging from 0% to 45%. The graph shows increasing percentages from the placebo group to the higher dose Levetiracetam group.*

FDA Label Image

Figure 6 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 06)

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) with 14.4% and Levetiracetam 3000 mg/day (N=180) with 39.4%. The y-axis represents the percentage of patients, ranging from 0% to 45%. A marker indicates a notable value for the Levetiracetam group.*

FDA Label Image

Figure 7 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 07)

A bar chart comparing the percentage of patients in two groups: Placebo (97 patients) and Levetiracetam (101 patients). The y-axis represents percentage of patients, ranging from 0% to 45%. The Placebo group shows 19.6%, and the Levetiracetam group shows 44.6%.*

FDA Label Image

Figure 8 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 08)

Bar chart comparing the percentage of patients in two groups: Placebo (N=51) at 19.6% and Levetiracetam (N=58) at 43.1%. The y-axis represents the percentage of patients from 0% to 45%. Asterisk marks the Levetiracetam bar, indicating significance.*

FDA Label Image

Figure 9 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 09)

A bar chart comparing the percentage of patients in two groups: Placebo (N=84) and Levetiracetam (N=79). The y-axis shows the percentage of patients from 0% to 100%. The Placebo group has 45.2%, and the Levetiracetam group has 72.2%, with an asterisk above the Levetiracetam bar indicating statistical significance.*

FDA Label Image

Label (Sdistributi19051411500 0001)

Label for Levetiracetam 500 mg tablets, containing 20 tablets. The label shows the NDC 67296-1636-2, prescription-only status, lot number 802115 1, and expiration date 04/21. Manufactured by Lupin Limited, India, and distributed by RedPharm Drug, Inc., Eden Prairie, MN. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.